跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 131,759 条关于
“ovarian clear cell cancer”
全部
131,759
临床试验
102,789
药物
6,410
机构
1,225
资讯
21,335
8个月前
LIXTE Biotechnology Doubles Enrollment in Ovarian Clear Cell Cancer Trial Combining LB-100 with GSK's Dostarlimab
去年
Northwestern's Lurie Cancer Center Joins Clinical Trial Testing LIXTE's LB-100 Plus Dostarlimab for Ovarian Clear Cell Cancer
上个月
IL-17-Driven Inflammatory Program Reveals Immunotherapy-Permissive Subtype in Clear Cell Ovarian Cancer
5个月前
Singapore-Led Studies Demonstrate Breakthrough Treatments for Challenging Women's Cancers
2年前
Lixte Biotechnology's LB-100 Shows Promise in Multiple Cancer Indications Through Novel PP2A Inhibition
6个月前
FDA Places Partial Clinical Hold on MacroGenics' Lorigerlimab Trial Following Severe Safety Events
去年
Nature Study Validates LIXTE's PP2A Inhibitor LB-100 for Enhanced Cancer Immunotherapy
8个月前
BioInvent's BI-1808 Plus Pembrolizumab Shows 24% Response Rate in Recurrent Ovarian Cancer
去年
MacroGenics Secures $70 Million in ZYNYZ Royalty Deal, Extends Cash Runway Through 2027
去年
PPP2R1A Mutations Predict Improved Survival After Cancer Immunotherapy in Ovarian Clear Cell Carcinoma
第 1 页，共 2134 页
上一页
下一页
